Independent association of urinary F2-isoprostanes with survival in pulmonary arterial hypertension.
Standard
Independent association of urinary F2-isoprostanes with survival in pulmonary arterial hypertension. / Cracowski, Jean-Luc; Degano, Bruno; Chabot, François; Labarère, José; Schwedhelm, Edzard; Monneret, Denis; Iuliano, Luigi; Schwebel, Carole; Chaouat, Ari; Reynaud-Gaubert, Martine; Faure, Patrice; Maas, Renke; Renversez, Jean-Charles; Cracowski, Claire; Sitbon, Olivier; Yaïci, Azzedine; Simonneau, Gerald; Humbert, Marc.
In: CHEST, Vol. 142, No. 4, 4, 2012, p. 869-876.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Independent association of urinary F2-isoprostanes with survival in pulmonary arterial hypertension.
AU - Cracowski, Jean-Luc
AU - Degano, Bruno
AU - Chabot, François
AU - Labarère, José
AU - Schwedhelm, Edzard
AU - Monneret, Denis
AU - Iuliano, Luigi
AU - Schwebel, Carole
AU - Chaouat, Ari
AU - Reynaud-Gaubert, Martine
AU - Faure, Patrice
AU - Maas, Renke
AU - Renversez, Jean-Charles
AU - Cracowski, Claire
AU - Sitbon, Olivier
AU - Yaïci, Azzedine
AU - Simonneau, Gerald
AU - Humbert, Marc
PY - 2012
Y1 - 2012
N2 - Within the past decade, biochemical markers have emerged as attractive tools to assess pulmonary arterial hypertension (PAH) prognosis, being noninvasive and easily repeatable.The objective of this study was to determine whether biomarkers measured at initial diagnostic right-sided heart catheterization predict 3-year all-cause mortality for incident cases of PAH independently of clinical and hemodynamic parameters.
AB - Within the past decade, biochemical markers have emerged as attractive tools to assess pulmonary arterial hypertension (PAH) prognosis, being noninvasive and easily repeatable.The objective of this study was to determine whether biomarkers measured at initial diagnostic right-sided heart catheterization predict 3-year all-cause mortality for incident cases of PAH independently of clinical and hemodynamic parameters.
KW - Humans
KW - Male
KW - Female
KW - Middle Aged
KW - Risk Factors
KW - Prognosis
KW - Follow-Up Studies
KW - Retrospective Studies
KW - Enzyme-Linked Immunosorbent Assay
KW - Kaplan-Meier Estimate
KW - Lipid Peroxidation
KW - Survival Rate/trends
KW - France/epidemiology
KW - Gas Chromatography-Mass Spectrometry
KW - Biological Markers/urine
KW - Cause of Death/trends
KW - F2-Isoprostanes/urine
KW - Hypertension, Pulmonary/enzymology/mortality
KW - Humans
KW - Male
KW - Female
KW - Middle Aged
KW - Risk Factors
KW - Prognosis
KW - Follow-Up Studies
KW - Retrospective Studies
KW - Enzyme-Linked Immunosorbent Assay
KW - Kaplan-Meier Estimate
KW - Lipid Peroxidation
KW - Survival Rate/trends
KW - France/epidemiology
KW - Gas Chromatography-Mass Spectrometry
KW - Biological Markers/urine
KW - Cause of Death/trends
KW - F2-Isoprostanes/urine
KW - Hypertension, Pulmonary/enzymology/mortality
M3 - SCORING: Journal article
VL - 142
SP - 869
EP - 876
JO - CHEST
JF - CHEST
SN - 0012-3692
IS - 4
M1 - 4
ER -